GI ALLE MULIGHET TIL Å INVESTERE I VEKSTSELSKAPER GJENNOM AKSJEKJØP. Folkeinvest AS ønsker med webtjenesten folkeinvest.no å demokratisere investering i oppstartsselskaper.Emisjonsprosessen har frem til nå være komplisert både for selskapet og de som vil investere. Derfor har slike investeringer vanligvis kun blitt tilbudt bekjente av selskapet og profesjonelle investorer.Folkefinansiering med lave minstebeløp og en lettfattelig webtjeneste gir alle mulighet til å investere.Å investere i oppstartsselskaper er forbundet med risiko for at investeringen kan gå tapt. Mange selskaper overlever ikke sine fem første år. Men det er også i den fasen at verdistigningen kan bli høy. Vi mener at denne investeringsmuligheten bør være tilgjengelig for alle.Folkeinvest.no har åpne investorlister, diskusjonsforum og krav til dokumentasjon som gjør at aksjekjøpere er godt rustet til å ta investeringsbesluttninger.

Emberly is a Stavanger-based startup founded in 2020. The company was born out of a desire to help people learn better and to help them manage information overload. Our product is a knowledge library, but in contrast to other solutions, we help you organize your knowledge into what we call "knowledge maps". Traditional solutions based on tags and search are not adequate due to the simple fact that it requires using the language center of the brain, this requires you to break your chain of thought before you can even start looking for your resources. Emberly in contrast, lets you use spatial navigation to find what you are looking for. Which is far more efficient.Not to mention the fact that by creating and using this breakdown of topics, you automatically gain a far better understanding of the concepts you are working on. We have been working tightly knit with our community for two years to help us make Emberly the best experience it can be, and we officially released the system in 2022.

UpStacked is the All-in-One centralized operations platform that crushes SLA requirements to increase profitability and reduce OPEX. Purpose-built for internal IT and MSPs to operate SMBs and Enterprises. With user experience in mind, UpStacked drives complex to zero-touch, through automation and machine learning. UpStacked at a Glance: - All-in-One Centralized Platform - Enterprise onboarding in minutes - Third-Party integrations - Zero-Touch - Simplified License Management - Real-Time On-Demand Reporting - Real-Time Topology Based Correlation - Real-Time Event-Based Correlation - Built-in Role Based Access Control - Natively Multi-Tenant - Multi-Vendor - ITIL

Speak Norsk is an ambitious team that started with one goal in mind – to make expats fluent in Norwegian! We are passionate about language-learning and bringing to Norway a new, innovative way of teaching Norwegian. Since the beginning, we have been known for our interactive conversation-focused classes, own-written books, and something that it´s not quite common for other schools – a personal approach and a customized offer for each one of our students. Meet our passionate and united team of Speak Norsk school!

Movel AS provides support and invoicing services for AC charging systems. We specialize in systems that provide normal charging for long-term and overnight parking. Movel wants to contribute to a more environmentally friendly life. Therefore, all power in Movel's charging systems provides renewable energy.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

Anzyz is an Artificial Intelligence company, which uniquely integrates supervised, unsupervised and manual rule-based learning through a text analytical algorithm, called CCL (Corpus Cube Linguistics). CCL is self-learning and enables interpretation and understanding of the contextual meaning in Big Data. CCL stems from innovations led by Professor Ole-Christoffer Granmo at the University of Agder. Granmo and entrepreneur Svein Olaf Olsen established Anzyz Technologies AS in 2014. The company seeks to become one of the world's leading providers of Artificial Intelligence - driven business solutions.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

LifeTools AS develops digital tools for people with complex needs within the fields of communication, cognition, and challenged behavior. We put the user first and develop dynamic systems with high flexibility based on the unique user's needs. The network around the user will have digital tools to observe, build and publish expressions, routines, and activities into our systems, and use this information back into the interaction with the user. This gives a better foundation in communication and helps increase the quality of life for the user. Our philosophy is to use "everyday technology" such as tablets/phones and cloud-based solutions and develop highly intuitive and dynamic tools for the network. Users (people with special and complex needs) therefore do not need to acquire skills or knowledge in order to use our systems. This makes it easier for those who have great cognitive challenges to make use of our technological solutions.

We start our project in 2017. We develop and offer to the market ecological & sustainable fertilizers made by mineral and organic nature. We cultivate a unique product and engage experience and innovation. By offering a quality product with added value to our customers, we help make a cost-effective solution for horticulture and agriculture.  We are happy to be engaged in the optimization of performance for allied businesses and private customers.

Da jeg brenner for startups - strekker jeg meg langt hvis det er noe jeg kan hjelpe med - forutsetter at: 1. Jeg liker ideen. 2. Jeg liker menneskene.Fått noen spørsmål om jeg vil være co-founder. Men så lenge jeg har min egen startup ide så prioriterer jeg jobbe med egne ting. Men som sagt -  jeg kan hjelpe med noe så er det bare å spørre.

In the autumn of 2016 was CSI Marine Cleaning AS [CSI] established and included in Validé's incubation program with our idea for a ship hull cleaner and cleaning of other structures submerges in the sea. CSI's idea and goal with this unit are to collect 100% of all bio-marine fouling that comes off of the surface while cleaning. The collected fouling will then be rendered harmless by killing all bio-marine life that is collected before returning it back to the sea. As of date, there is no ship hull cleaner that can document 100% collection of the fouling. Competitive ship hull cleaners vary in the collection of the bio-marine fouling from 25μm and upwards. The need for collection is as low as 2μm according to a study.CSI has secured letters of intent with Yanmar Co. LTD., Østerbø Maskin AS, and Optimarin AS with regard to the development of the collection system and ship hull cleaning unit. CSI has also in the letter of intent with Optimarin AS secured exclusive rights for use of their technology in our line of business. Furthermore, CSI has secured letters of intent with Teekay Shipping Norge AS and Transpetrol Tm AS stating their interest in the finalized product. They may intend to use the cleaning service if the product function as described and the service has competitive pricing.  Information about the development project: The technology for the collection system needs to be developed as a prototype. When it's developed the prototype will be fitted to Yanmar's net cleaner that will be modified for solid surfaces and connected to Optimarin's technology for filter and UV treatment. The cleaning speed is about 1500m2 per hour and is using water pressure in three rotating disks for cleaning the surfaces. iCsys AS will be engaged with implementing sensors and creating unique 3D-mapping software. iCsys will also implement autonomic features for the unit. Regarding research and documentation, we will involve Christian Michelsen Research AS that will document the effectiveness of the finalized unit. Østerbø Maskin will assist with CAD, engineering, and manufacturing of the unit.CSI intends to apply for Innovation Norway's Environmental technology program to start the development of this unit, thus searching for companies or investors willing to finance this project.

WindTechVi er et tidlig fase prosjekt som jobber med utvikling av teknologi og risikostyringssystemer for kaldt klima. Vi jobber med en løsning på et identifisert problem, som vi ønsker å videre utvikle og kommersialisere. Her er de hovedaktivitetene som vi har gjennomført siden september 2016; - Prototype 1 simulering - Kommersiell vurdering - Markedsavklaring og forretningsutvikling - Pitche konkurranse (100’) - Styrket teamet med produktutvikler - VRI midler - Prototype 2 test i lab - Prototype 3 test i felt - Pre-inkubasjons avtale Veien videre - Styrke laget - Videre markedsavklaring og kontakt med industri - Forretningsutvikling og produktutvikling - Hente inn midler (IN – Markedsavklaring, FNY student ) - Etablere selskap Les mer på www.windtech.no Vi tar gjerne en prat med deg om du er interessert i å bli en del av WindTech Ta kontakt med Daniel Swart på 986 48 723 eller daniel@windtech.no

Greensight - grønn energiomstilling gjort enkelt.Mangelen på oppdatert og lett tilgjengelig høykvalitets informasjon om grønne energiløsninger, næringer og  markeder hindrer bedrifter og kommuner fra å velge bærekraftige og framtidsrettede løsninger. Veldig mange beslutningstakerne har verken tid eller kunnskap til å vurdere nye løsninger, og innovative, grønne og lønnsome løsninger blir ofte oversett. Greensight jobber med å bygge beslutningstøtteverktøy basert på oppdatert og kvalitetskontrollert informasjon om grønn teknologi, løsninger og markeder. Dette gir brukere mulighet til å få tilgang til gode, oppdaterte og visuelle data og analyser som er tilpasset brukerens prosjekter og virksomhet.Greensight AS er et datterselskap av Greenstat AS.

VIBRO har som mål å gjennomføre verdiskapende prosjekter som skaper muligheter for unge mennesker. Innen 2021 skal VIBRO ha skapt muligheter for 1000 unge mennesker. VIBRO jobber for å avdekke samfunnsproblemer knyttet til unge mennesker. Utvikle og gjennomføre verdiskapende prosjekter knyttet til samfunnsproblemer. VIBRO Rekruttere unge mennesker som selv ønsker å bryte ned barrierer og bidra til kompetanseheving for disse . På denne måten skaper vi verdi for unge mennesker i samfunnet, partnere og kunder.